The Oxford spinout has lured funding from OSI and the university itself as it aims to meet performance milestones for its peptide drug discovery programs.
Orbit Discovery, a UK-based peptide discovery spinout from University of Oxford, has closed a £6.9m ($9.1m) series A round led by university venture fund Oxford Sciences Innovation (OSI).
The round also included University of Oxford itself, as well as IT services provider RT Ventures, Borealis Ventures and Perivoli Innovations, a subsidiary of investment group Perivoli Trust.
Oxford Technology and Innovations EIS Fund, managed by investment advisory partnership Oxford Investment Consultants, also took part, as did OT(S)EIS Fund, managed by…
